ROCHE HOLDING LTD (RHHBF)
Clinical trial NCT00781612 updates: 1. completion date: 2026-11-28 → 2027-06-30 2. primary completion date: 2026-10-31 → 2027-06-30
Clinical trial NCT00781612 updates: 1. completion date: 2026-11-28 → 2027-06-30 2. primary completion date: 2026-10-31 → 2027-06-30
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical